Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bright Minds Biosciences Inc (CN: DRUG)

 
DRUG Technical Analysis
5
As on 7th Jan 2026 DRUG STOCK Price closed @ 130.08 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 56.00 & Strong Buy for SHORT-TERM with Stoploss of 54.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRUGSTOCK Price

Open 122.00 Change Price %
High 134.53 1 Day 5.13 4.11
Low 113.43 1 Week 12.08 10.24
Close 130.08 1 Month 48.08 58.63
Volume 7703 1 Year 68.87 112.51
52 Week High 131.88 | 52 Week Low 33.43
 
CN Canada Most Active Stocks
BIGG 0.22 15.79%
ASE 2.41 9.55%
ACDC 0.06 0.00%
FMAN 0.55 7.84%
DIGI 0.04 33.33%
PAU 0.26 -7.14%
KUYA 0.87 -8.42%
TER 2.80 5.66%
SOL 0.02 0.00%
PAID 0.03 50.00%
 
CN Canada Top Gainers Stocks
MIS 0.32 433.33%
JBR 0.02 100.00%
LLL 0.10 100.00%
LLL 0.10 100.00%
ASTI 0.02 100.00%
ASTI 0.02 100.00%
CAT 0.02 100.00%
CAT 0.02 100.00%
CAT 0.02 100.00%
CAT 0.02 100.00%
 
CN Canada Top Losers Stocks
SPFY 0.00 -100.00%
GTG 0.37 -97.30%
GTG 0.37 -97.30%
CODE 1.20 -65.12%
CODE 1.20 -65.12%
XBLK 0.02 -50.00%
BBM 0.01 -50.00%
BYT 0.12 -42.86%
IMCC 5.10 -40.00%
IMCC 5.10 -40.00%
 
 
DRUG
Daily Charts		 DRUG
Intraday Charts		 Whats New @
Bazaartrend		 DRUG
Free Analysis
 
DRUG Important Levels Intraday
RESISTANCE170.74
RESISTANCE157.70
RESISTANCE149.64
RESISTANCE141.58
SUPPORT118.58
SUPPORT110.52
SUPPORT102.46
SUPPORT89.42
 
DRUG Forecast January 2026
Share
4th UP Forecast174.38
3rd UP Forecast160.17
2nd UP Forecast151.39
1st UP Forecast142.61
1st DOWN Forecast117.55
2nd DOWN Forecast108.77
3rd DOWN Forecast99.99
4th DOWN Forecast85.78
 
DRUG Weekly Forecast
4th UP Forecast146.86
3rd UP Forecast141.48
2nd UP Forecast138.15
1st UP Forecast134.83
1st DOWN Forecast125.33
2nd DOWN Forecast122.01
3rd DOWN Forecast118.68
4th DOWN Forecast113.30
 
DRUG Forecast2026
4th UP Forecast394.06
3rd UP Forecast309.4
2nd UP Forecast257.07
1st UP Forecast204.74
1st DOWN Forecast55.42
2nd DOWN Forecast3.09
3rd DOWN Forecast-49.24
4th DOWN Forecast-133.9
 
 
DRUG Other Details
Segment EQ
Market Capital 101184120.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
DRUG Address
DRUG
 
DRUG Latest News
 
Your Comments and Response on Bright Minds Biosciences Inc
 
DRUG Business Profile
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Address: 1500 ? 1055 West Georgia Street, Vancouver, BC, Canada, V6E 4N7
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service